Compare $GIPL vs $GTHP | Chartloom

Compare

$GIPL vs $GTHP

Global Innovative Platforms Inc · Guided Therapeutics Inc

GIPL

Global Innovative Platforms Inc

GTHP

Guided Therapeutics Inc

Compare $GIPL vs $GTHP

Comparing Global Innovative Platforms Inc and Guided Therapeutics Inc

GIPLGlobal Innovative Platforms Inc

GTHPGuided Therapeutics Inc

GIPLGlobal Innovative Platforms Inc

Market cap

$25M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.8%

52W performance

-100.0%

FCF yield

-2.6%

GTHPGuided Therapeutics Inc

Market cap

$19M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

450.8%

YTD performance

-63.0%

52W performance

-20.0%

FCF yield

-7.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GIPL

GTHP

Detailed metrics comparison

GIPL

Global Innovative Platforms Inc

GTHP

Guided Therapeutics Inc

Market Cap

GIPL$25M

GTHP$19M

Enterprise Value

GIPL$24M

GTHP$21M

Price

GIPL$0.50

GTHP$0.20

P/E Ratio

GIPLN/A

GTHPN/A

P/S Ratio

GIPL131.14x

GTHP29.70x

EV/Sales

GIPL129.87x

GTHP32.92x

EV/EBITDA

GIPL0.00x

GTHP0.00x

P/B Ratio

GIPL46.81x

GTHP33.42x

P/FCF Ratio

GIPLN/A

GTHPN/A

EV/FCF

GIPL-38.35x

GTHP-14.21x

PEG Ratio

GIPLN/A

GTHPN/A

Forward P/E (NTM)

GIPLN/A

GTHPN/A

Forward P/S (NTM)

GIPLN/A

GTHPN/A

Revenue (TTM)

GIPL$187K

GTHP$650K

Revenue Growth (YoY)

GIPLN/A

GTHP450.8%

Forward Rev Growth

GIPL0.0%

GTHP0.0%

Gross Margin (TTM)

GIPL0.0%

GTHP75.8%

Operating Margin (TTM)

GIPL0.0%

GTHP0.0%

EBITDA Margin (TTM)

GIPL-220.2%

GTHP-336.2%

Net Margin (TTM)

GIPL-361.6%

GTHP-560.6%

FCF Margin (TTM)

GIPL-338.7%

GTHP-231.7%

Net Income (TTM)

GIPL$-677K

GTHP$-4M

FCF (TTM)

GIPL$-634K

GTHP$-2M

EPS (TTM)

GIPL-$0.01

GTHP-$0.04

ROE (TTM)

GIPL-18448.0%

GTHP-47148.0%

ROA (TTM)

GIPL-17411.0%

GTHP-24393.0%

ROIC (TTM)

GIPL-18322.0%

GTHP-37126.0%

Cash

GIPL$244K

GTHP$12K

Debt

GIPL$6K

GTHP$2M

Net Cash/Debt

GIPL$239K

GTHP$-2M

Current Ratio (TTM)

GIPL34.74x

GTHP0.09x

Quick Ratio (TTM)

GIPL33.24x

GTHP0.00x

Debt/Equity (TTM)

GIPL0.01x

GTHP0.60x

Debt/Assets (TTM)

GIPL0.0%

GTHP0.0%

Interest Coverage (TTM)

GIPLN/A

GTHPN/A

Net Debt/EBITDA (TTM)

GIPL0.00x

GTHP0.00x

Beta

GIPL11,145.93

GTHP0.69

52W Performance

GIPL-100.0%

GTHP-20.0%

YTD Performance

GIPL-3.8%

GTHP-63.0%

% from 52W High

GIPL-100.0%

GTHP-63.0%

% from 52W Low

GIPL400.0%

GTHP66.7%

Asset Turnover (TTM)

GIPL0.00x

GTHP0.73x

FCF Yield (TTM)

GIPL-2.6%

GTHP-7.8%

Earnings Yield (TTM)

GIPL-2.8%

GTHP-18.9%

Dividend Yield (TTM)

GIPLN/A

GTHPN/A

Rule of 40

GIPL-338.7

GTHP219.2

EV/GP/RG

GIPLN/A

GTHPN/A

Ticker research

View GIPL research View GTHP research

Metric	GIPL Global Innovative Platforms Inc	GTHP Guided Therapeutics Inc
Market & Valuation
Market Cap	$25M	$19M
Enterprise Value	$24M	$21M
Price	$0.50	$0.20
P/E Ratio	N/A	N/A
P/S Ratio	131.14x	29.70x
EV/Sales	129.87x	32.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	46.81x	33.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-38.35x	-14.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$187K	$650K
Revenue Growth (YoY)	N/A	450.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	75.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-220.2%	-336.2%
Net Margin (TTM)	-361.6%	-560.6%
FCF Margin (TTM)	-338.7%	-231.7%
Net Income (TTM)	$-677K	$-4M
FCF (TTM)	$-634K	$-2M
EPS (TTM)	-$0.01	-$0.04
ROE (TTM)	-18448.0%	-47148.0%
ROA (TTM)	-17411.0%	-24393.0%
ROIC (TTM)	-18322.0%	-37126.0%
Financial Health
Cash	$244K	$12K
Debt	$6K	$2M
Net Cash/Debt	$239K	$-2M
Current Ratio (TTM)	34.74x	0.09x
Quick Ratio (TTM)	33.24x	0.00x
Debt/Equity (TTM)	0.01x	0.60x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	11,145.93	0.69
52W Performance	-100.0%	-20.0%
YTD Performance	-3.8%	-63.0%
% from 52W High	-100.0%	-63.0%
% from 52W Low	400.0%	66.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.73x
FCF Yield (TTM)	-2.6%	-7.8%
Earnings Yield (TTM)	-2.8%	-18.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-338.7	219.2
EV/GP/RG	N/A	N/A
Ticker research	View GIPL research	View GTHP research

Valuation

P/S Ratio

GTHP

29.70x

GIPL

131.14x

EV/FCF

GIPL

-38.35x

GTHP

-14.21x

Growth & revenue

Revenue Growth TTM

GTHP

450.8%

Forward Revenue Growth

GIPL

0.0%

GTHP

0.0%

Profitability & performance

Gross Margin

GTHP

75.8%

GIPL

0.0%

ROE

GIPL

-18448.0%

GTHP

-47148.0%

FCF Yield %

GIPL

-2.6%

GTHP

-7.8%

52-Week Performance

GTHP

-20.0%

GIPL

-100.0%

Detailed metrics comparison

GIPL

Global Innovative Platforms Inc

GTHP

Guided Therapeutics Inc

Market Cap

GIPL$25M

GTHP$19M

Enterprise Value

GIPL$24M

GTHP$21M

Price

GIPL$0.50

GTHP$0.20

P/E Ratio

GIPLN/A

GTHPN/A

P/S Ratio

GIPL131.14x

GTHP29.70x

EV/Sales

GIPL129.87x

GTHP32.92x

EV/EBITDA

GIPL0.00x

GTHP0.00x

P/B Ratio

GIPL46.81x

GTHP33.42x

P/FCF Ratio

GIPLN/A

GTHPN/A

EV/FCF

GIPL-38.35x

GTHP-14.21x

PEG Ratio

GIPLN/A

GTHPN/A

Forward P/E (NTM)

GIPLN/A

GTHPN/A

Forward P/S (NTM)

GIPLN/A

GTHPN/A

Revenue (TTM)

GIPL$187K

GTHP$650K

Revenue Growth (YoY)

GIPLN/A

GTHP450.8%

Forward Rev Growth

GIPL0.0%

GTHP0.0%

Gross Margin (TTM)

GIPL0.0%

GTHP75.8%

Operating Margin (TTM)

GIPL0.0%

GTHP0.0%

EBITDA Margin (TTM)

GIPL-220.2%

GTHP-336.2%

Net Margin (TTM)

GIPL-361.6%

GTHP-560.6%

FCF Margin (TTM)

GIPL-338.7%

GTHP-231.7%

Net Income (TTM)

GIPL$-677K

GTHP$-4M

FCF (TTM)

GIPL$-634K

GTHP$-2M

EPS (TTM)

GIPL-$0.01

GTHP-$0.04

ROE (TTM)

GIPL-18448.0%

GTHP-47148.0%

ROA (TTM)

GIPL-17411.0%

GTHP-24393.0%

ROIC (TTM)

GIPL-18322.0%

GTHP-37126.0%

Cash

GIPL$244K

GTHP$12K

Debt

GIPL$6K

GTHP$2M

Net Cash/Debt

GIPL$239K

GTHP$-2M

Current Ratio (TTM)

GIPL34.74x

GTHP0.09x

Quick Ratio (TTM)

GIPL33.24x

GTHP0.00x

Debt/Equity (TTM)

GIPL0.01x

GTHP0.60x

Debt/Assets (TTM)

GIPL0.0%

GTHP0.0%

Interest Coverage (TTM)

GIPLN/A

GTHPN/A

Net Debt/EBITDA (TTM)

GIPL0.00x

GTHP0.00x

Beta

GIPL11,145.93

GTHP0.69

52W Performance

GIPL-100.0%

GTHP-20.0%

YTD Performance

GIPL-3.8%

GTHP-63.0%

% from 52W High

GIPL-100.0%

GTHP-63.0%

% from 52W Low

GIPL400.0%

GTHP66.7%

Asset Turnover (TTM)

GIPL0.00x

GTHP0.73x

FCF Yield (TTM)

GIPL-2.6%

GTHP-7.8%

Earnings Yield (TTM)

GIPL-2.8%

GTHP-18.9%

Dividend Yield (TTM)

GIPLN/A

GTHPN/A

Rule of 40

GIPL-338.7

GTHP219.2

EV/GP/RG

GIPLN/A

GTHPN/A

Ticker research

View GIPL research View GTHP research

Metric	GIPL Global Innovative Platforms Inc	GTHP Guided Therapeutics Inc
Market & Valuation
Market Cap	$25M	$19M
Enterprise Value	$24M	$21M
Price	$0.50	$0.20
P/E Ratio	N/A	N/A
P/S Ratio	131.14x	29.70x
EV/Sales	129.87x	32.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	46.81x	33.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-38.35x	-14.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$187K	$650K
Revenue Growth (YoY)	N/A	450.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	75.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-220.2%	-336.2%
Net Margin (TTM)	-361.6%	-560.6%
FCF Margin (TTM)	-338.7%	-231.7%
Net Income (TTM)	$-677K	$-4M
FCF (TTM)	$-634K	$-2M
EPS (TTM)	-$0.01	-$0.04
ROE (TTM)	-18448.0%	-47148.0%
ROA (TTM)	-17411.0%	-24393.0%
ROIC (TTM)	-18322.0%	-37126.0%
Financial Health
Cash	$244K	$12K
Debt	$6K	$2M
Net Cash/Debt	$239K	$-2M
Current Ratio (TTM)	34.74x	0.09x
Quick Ratio (TTM)	33.24x	0.00x
Debt/Equity (TTM)	0.01x	0.60x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	11,145.93	0.69
52W Performance	-100.0%	-20.0%
YTD Performance	-3.8%	-63.0%
% from 52W High	-100.0%	-63.0%
% from 52W Low	400.0%	66.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.73x
FCF Yield (TTM)	-2.6%	-7.8%
Earnings Yield (TTM)	-2.8%	-18.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-338.7	219.2
EV/GP/RG	N/A	N/A
Ticker research	View GIPL research	View GTHP research